Our team has decades of experience in managing brands, portfolios, and departments. We provide strategic analyses and recommendations that are both meaningful and actionable. We have been involved in due diligence all around the world assessing both drug and diagnostic assets.
We are driven by data. We analyze and interpret data to make strategic recommendations. We use recommendations to identify the best options that drive value.
Competitive benchmarking
New product planning
Situation analysis
Opportunity assessment
Promotional effectiveness and ROI
Secondary data analysis
Pipeline and portfolio gap analysis
Asset prioritization
